ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,233Medicare Part D Prescriptions Filled, Including Refills

Rank: 231 out of 1000

$478K Total Retail Price of All Prescriptions

Rank: 271 out of 1000

445 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 5,514 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 648 276 1 2
SIMVASTATIN 537 329 2 3
METFORMIN HCL 430 208 3 8
FUROSEMIDE 353 164 4 7
LISINOPRIL 352 160 5 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 265 158 6 20
GEMFIBROZIL 251 95 7 105
POTASSIUM CHLORIDE 243 125 8 10
DICLOFENAC SODIUM 206 49 9 123
RANITIDINE HCL 204 89 10 37
GABAPENTIN 180 111 11 11
LEVOTHYROXINE SODIUM 168 72 12 4
METOPROLOL TARTRATE 164 102 13 19
TRAMADOL HCL 161 95 14 13
GLIMEPIRIDE 158 70 15 34
MELOXICAM 153 58 16 14
TRICOR 149 63 17 141
DOXAZOSIN MESYLATE 147 90 18 111
CITALOPRAM HBR 142 89 19 17
ATENOLOL 127 52 20 24
CRESTOR 124 32 21 30
POLYETHYLENE GLYCOL 3350 123 22 22 69
SPIRONOLACTONE 122 68 23 78
DIGOXIN 119 94 24 52
ACTOS 109 26 25 119
WARFARIN SODIUM 107 87 26 22
HYDROCHLOROTHIAZIDE 106 59 27 9
ATORVASTATIN CALCIUM 105 39 28 18
ALBUTEROL SULFATE 98 40 29 142
ATENOLOL-CHLORTHALIDONE 98 70 29 206
CIPROFLOXACIN HCL 94 50 31 46
NEXIUM 89 37 32 23
TRIAMTERENE-HCTZ 87 53 33 48
CARVEDILOL 82 27 34 15
AMLODIPINE BESYLATE 82 40 34 6
AMITRIPTYLINE HCL 81 50 R 36 45
ALLOPURINOL 80 56 37 31
CLONIDINE HCL 78 49 38 27
PREDNISONE 77 47 39 42
DONEPEZIL HCL 75 64 40 32
OXYBUTYNIN CHLORIDE 75 32 40 145
METHOCARBAMOL 70 29 R 42 79
DILTIAZEM 24HR CD 69 55 43 136
TAMSULOSIN HCL 67 48 44 33
LOVASTATIN 67 31 44 41
PAROXETINE HCL 64 30 46 63
FLUTICASONE PROPIONATE 64 24 46 40
SPIRIVA 62 28 48 64
AMOXICILLIN 61 25 49 89
SULINDAC 58 54 50 245
DETROL LA 57 0 51 208
FAMOTIDINE 57 0 51 88
LOSARTAN POTASSIUM 57 25 51 25
GLIPIZIDE 55 30 54 62
BUSPIRONE HCL 55 37 54 110
FLUCONAZOLE 54 11 56 102
CLOPIDOGREL 53 45 57 35
LACTULOSE 53 0 57 162
CARBAMAZEPINE 52 36 59 225
PLAVIX 52 45 59 49
ETODOLAC 50 0 61 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.